Bd to present at ubs genomics 2.0 and medtech innovations summit

Franklin lakes, n.j., july 29, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that management will be presenting at the ubs genomics 2.0 and medtech innovations summit on wednesday, august 11, 2021, at 4:00 p.m.

BDX Ratings Summary

BDX Quant Ranking